Office of Collaborative Biostatistics

$772,554ZIDFY2025CANIH

Division Of Clinical Sciences - Nci

Investigators

Linked publications, trials & patents

Paper 38758582 Paper 38706610 Paper 38669315 Paper 38581118 Paper 38398093 Paper 38309720 Paper 38265793 Paper 38205877 Paper 38184304 Paper 37877369 Paper 37584292 Paper 37217721 Paper 37115514 Paper 37024617 Paper 37011643 Paper 36810713 Paper 36754451 Paper 36732510 Paper 36705597 Paper 36595377 Paper 36456359 Paper 36346688 Paper 36302175 Paper 36302173 Paper 36208017 Paper 36201744 Paper 35605184 Paper 35535581 Paper 35482927 Paper 35274717 Paper 35274710 Paper 35143622 Paper 35114411 Paper 35031545 Paper 34875023 Paper 34862247 Paper 34767461 Paper 34687939 Paper 34580862 Paper 34149696 Paper 34140245 Paper 34104639 Paper 33908897 Paper 33848478 Paper 33785256 Paper 33764809 Paper 33720337 Paper 33627472 Paper 33594772 Paper 33554406 Paper 33554060 Paper 33526918 Paper 33504652 Paper 33441339 Paper 33405090 Paper 33397682 Paper 33333207 Paper 33315718 Paper 33262136 Paper 32976576 Paper 32969563 Paper 32572140 Paper 32453640 Paper 32402293 Paper 32398945 Paper 32398324 Paper 32343743 Paper 32327394 Paper 32314030 Paper 32286905 Paper 32284398 Paper 32276276 Paper 32270710 Paper 32269146 Paper 32187457 Paper 32163525 Paper 32152628 Paper 32109194 Paper 32084506 Paper 32000167 Paper 31996388 Paper 31943534 Paper 31903638 Paper 31896599 Paper 31792036 Paper 31594913 Paper 31586477 Paper 31493539 Paper 31447392 Paper 30817750 Paper 30761439 Paper 30227893 Paper 30139566 Paper 30054823 Paper 29933761 Paper 29718344 Paper 29097016 Paper 28792255 Paper 28638730 Paper 27839933

Abstract

The Office of Collaborative Biostatistics provides a broad range of data analysis and consultation services to laboratories performing basic scientific research into the origin and growth mechanisms of cancer. Other major collaborative efforts include studies to identify important prognostic and treatment selection factors, evaluate diagnostic procedures, develop improved staging systems, and assist investigators in the design, execution, and analyses of major in vitro drug testing studies. The Office develops and implements new statistical designs and biometric methods related to the development and evaluation of new cancer.

View original record on NIH RePORTER →